ADAPT OCULUS is the first study to evaluate a targeted treatment for ocular MG, demonstrating that VYVGART significantly improves disease symptoms in this underserved patient populationADAPT SERON, ...
One of my favourite Chaplains, known for his sense of humour, always starts his sermons with, “In the name of the Father, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results